Supriya Lifescience Limited (NSE: SUPRIYA)

Market Cap	47.89B
Revenue (ttm)	5.99B
Net Income (ttm)	1.35B
Shares Out	80.48M
EPS (ttm)	16.80
PE Ratio	35.42
Forward PE	n/a
Dividend	0.80 (0.13%)
Ex-Dividend Date	Sep 20, 2024

Volume	788,957
Open	583.75
Previous Close	583.75
Day's Range	569.00 - 614.70
52-Week Range	234.90 - 614.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Supriya Lifescience

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. It offers anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, and anti-malarial products, as well as vitamins and xanthine derivatives. The company was founded in 1987 and is headquartered in Mumbai, India.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1987
• Employees: 392
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SUPRIYA

Financial Performance

In 2023, SUPRIYA's revenue was 5.70 billion, an increase of 23.74% compared to the previous year's 4.61 billion. Earnings were 1.19 billion, an increase of 32.56%.